Cryogenx 🇬🇧
UK med-tech portable cooling for heatstroke treatment
About Cryogenx
Cryogenx has developed a portable body cooling device designed to rapidly reduce core temperature in cases of heatstroke, effectively emulating ice water immersion without the need for extensive resources. The CGX1 technology has undergone pre-clinical evaluations demonstrating its safety and efficacy, and it is intended for use in various high-risk environments such as military, sports, and industrial settings.
Cryogenx is a UK-based company founded in 2020, now around 10 people. It has raised $2.2M in disclosed funding.
Founder: Matt Anderson (Founder; previously Cubitts, Digital Kinematics; Brunel University of London).
Its investors also appear on FundFinder's most-active lists for Seed · DeepTech (80 funds), Seed · Climate & Sustainability (80 funds), Seed · Life Sciences (32 funds).
Company facts from Harmonic and public filings; team backgrounds from public profiles. Refreshed weekly.
Seed · £1.7m · Jul 2025
- UK Innovation & Science Seed Fund (UKI2S) — Evergreen, government-backed pre-seed+ fund managed by Future Planet Capital. · cheques up to £1.5M